CoChat

Structural and biochemical characterization of human Schlafen 5

Open access
Metzner, Felix J, Huber, Elisabeth, Hopfner, Karl-Peter, Lammens, Katja · 2022 · Nucleic Acids Research
Cited by 41

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The Schlafen family belongs to the interferon-stimulated genes and its members are involved in cell cycle regulation, T cell quiescence, inhibition of viral replication, DNA-repair and tRNA processing. Here, we present the cryo-EM structure of full-length human Schlafen 5 (SLFN5) and the high-resolution crystal structure of the highly conserved N-terminal core domain. We show that the core domain does not resemble an ATPase-like fold and neither binds nor hydrolyzes ATP. SLFN5 binds tRNA as well as single- and double-stranded DNA, suggesting a potential role in transcriptional regulation. Unlike rat Slfn13 or human SLFN11, human SLFN5 did not cleave tRNA. Based on the structure, we identified two residues in proximity to the zinc finger motif that decreased DNA binding when mutated. These results indicate that Schlafen proteins have divergent enzymatic functions and provide a structural platform for future biochemical and genetic studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkab1278

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 70

  1. Schwarz, 1998, Schlafen, a new family of growth regulatory genes that affect thymocyte development, Immunity, 9, 657, 10.1016/S1074-7613(00)80663-9 · DOI · Paper page
  2. Geserick, 2004, Modulation of t cell development and activation by novel members of the schlafen (slfn) gene family harbouring an RNA helicase-like motif, Int. Immunol., 16, 1535, 10.1093/intimm/dxh155 · DOI · Paper page
  3. Katsoulidis, 2009, Role of schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses, J. Biol. Chem., 284, 25051, 10.1074/jbc.M109.030445 · DOI · Paper page
  4. Katsoulidis, 2010, Role of interferon {alpha} (IFN{alpha})-inducible schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells, J. Biol. Chem., 285, 40333, 10.1074/jbc.M110.151076 · DOI · Paper page
  5. Brady, 2005, Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin d1, J. Biol. Chem., 280, 30723, 10.1074/jbc.M500435200 · DOI · Paper page
  6. Kuang, 2014, Schlafen 1 inhibits the proliferation and tube formation of endothelial progenitor cells, PLoS One, 9, e109711, 10.1371/journal.pone.0109711 · doi:10.1371/journal.pone.0109711
  7. Berger, 2010, An slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence, Nat. Immunol., 11, 335, 10.1038/ni.1847 · DOI · Paper page
  8. Puck, 2015, Expression and regulation of schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and t cells, Results Immunol, 5, 23, 10.1016/j.rinim.2015.10.001 · DOI
  9. Puck, 2017, The soluble cytoplasmic tail of CD45 (ct-CD45) in human plasma contributes to keep t cells in a quiescent state, Eur. J. Immunol., 47, 193, 10.1002/eji.201646405 · DOI
  10. Goldshtein, 2016, Loss of T-cell quiescence by targeting slfn2 prevents the development and progression of T-ALL, Oncotarget, 7, 46835, 10.18632/oncotarget.9390 · DOI
  11. Omar, 2016, Schlafen2 mutation unravels a role for chronic ER stress in the loss of t cell quiescence, Oncotarget, 7, 39396, 10.18632/oncotarget.9818 · DOI
  12. Basson, 2018, Schlafen 12 interaction with serpinb12 and deubiquitylases drives human enterocyte differentiation, Cell. Physiol. Biochem., 48, 1274, 10.1159/000492019 · DOI
  13. Kovalenko, 2014, Schlafen 12 expression modulates prostate cancer cell differentiation, J. Surg. Res., 190, 177, 10.1016/j.jss.2014.03.069 · DOI
  14. Lee, 2008, RANKL-induced schlafen2 is a positive regulator of osteoclastogenesis, Cell. Signal., 20, 2302, 10.1016/j.cellsig.2008.08.019 · DOI
  15. Mavrommatis, 2013, Expression and regulatory effects of murine schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma, J. Biol. Chem., 288, 33006, 10.1074/jbc.M113.460741 · DOI
  16. Tian, 2014, Schlafen-11 sensitizes colorectal carcinoma cells to irinotecan, Anticancer Drugs, 25, 1175, 10.1097/CAD.0000000000000151 · DOI · Paper page
  17. Zoppoli, 2012, Putative DNA/RNA helicase schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents, Proc. Natl. Acad. Sci. U.S.A., 109, 15030, 10.1073/pnas.1205943109 · DOI · Paper page
  18. Barretina, 2012, The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003 · DOI · Paper page
  19. Nogales, 2016, Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs, Oncotarget, 7, 3084, 10.18632/oncotarget.6413 · DOI · Paper page
  20. Lok, 2017, PARP inhibitor activity correlates with SLFN11 expression and demonstrates synergy with temozolomide in small cell lung cancer, Clin. Cancer Res., 23, 523, 10.1158/1078-0432.CCR-16-1040 · DOI · Paper page
  21. Murai, 2016, Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition, Oncotarget, 7, 76534, 10.18632/oncotarget.12266 · DOI · Paper page
  22. Gardner, 2017, Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis, Cancer Cell, 31, 286, 10.1016/j.ccell.2017.01.006 · DOI · Paper page
  23. Seong, 2017, Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication, Immunobiology, 222, 979, 10.1016/j.imbio.2017.07.002 · DOI
  24. Kim, 2021, Comparative proteomics identifies schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription, Nat Microbiol, 6, 234, 10.1038/s41564-020-00826-3 · DOI
  25. Chaturvedi, 2014, The P-loop region of schlafen 3 acts within the cytosol to induce differentiation of human caco-2 intestinal epithelial cells, Biochim. Biophys. Acta, 1843, 3029, 10.1016/j.bbamcr.2014.09.017 · DOI
  26. Neumann, 2008, Subcellular localization of the schlafen protein family, Biochem. Biophys. Res. Commun., 370, 62, 10.1016/j.bbrc.2008.03.032 · DOI
  27. Omar, 2017, Slfn2 mutation-induced loss of T-cell quiescence leads to elevated de novo sterol synthesis, Immunology, 152, 484, 10.1111/imm.12785 · DOI
  28. Fischietti, 2018, Slfn2 regulates type i interferon responses by modulating the NFkB pathway, Mol. Cell. Biol., 38, e00053-18, 10.1128/MCB.00053-18 · DOI
  29. Winkler, 2021, SLFN11 informs on standard of care and novel treatments in a wide range of cancer models, Br. J. Cancer, 124, 951, 10.1038/s41416-020-01199-4 · DOI
  30. Rathkey, 2020, Sensitivity of mesothelioma cells to PARP inhibitors is not dependent on BAP1 but is enhanced by temozolomide in cells with high-schlafen 11 and Low-O6-methylguanine-DNA methyltransferase expression, J. Thorac. Oncol., 15, 843, 10.1016/j.jtho.2020.01.012 · DOI · Paper page
  31. Takashima, 2021, Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers, Br. J. Cancer, 125, 65, 10.1038/s41416-021-01364-3 · DOI
  32. Coussy, 2020, BRCAness, SLFN11, and RB1 loss predict response to topoisomerase i inhibitors in triple-negative breast cancers, Sci. Transl. Med., 12, eaax2625, 10.1126/scitranslmed.aax2625 · DOI
  33. Kang, 2015, Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression, Clin. Cancer Res., 21, 1139, 10.1158/1078-0432.CCR-14-1882 · DOI · Paper page
  34. Allison Stewart, 2017, Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer, Oncotarget, 8, 28575, 10.18632/oncotarget.15338 · DOI · Paper page
  35. Okamoto, 2021, SLFN11 promotes stalled fork degradation that underlies the phenotype in fanconi anemia cells, Blood, 137, 336, 10.1182/blood.2019003782 · DOI
  36. Murai, 2021, SLFN11 inactivation induces proteotoxic stress and sensitizes cancer cells to ubiquitin activating enzyme inhibitor TAK-243, Cancer Res., 81, 3067, 10.1158/0008-5472.CAN-20-2694 · DOI
  37. Fletcher, 2018, Role of the novel endoribonuclease SLFN14 and its disease-causing mutations in ribosomal degradation, RNA, 24, 939, 10.1261/rna.066415.118 · DOI
  38. Pisareva, 2015, Characterization of novel ribosome-associated endoribonuclease SLFN14 from rabbit reticulocytes, Biochemistry, 54, 3286, 10.1021/acs.biochem.5b00302 · DOI · Paper page
  39. Sassano, 2015, Human schlafen 5 (SLFN5) is a regulator of motility and invasiveness of renal cell carcinoma cells, Mol. Cell. Biol., 35, 2684, 10.1128/MCB.00019-15 · DOI
  40. Gu, 2020, SLFN5 influences proliferation and apoptosis by upregulating PTEN transcription via ZEB1 and inhibits the purine metabolic pathway in breast cancer, Am J Cancer Res, 10, 2832
  41. Arslan, 2017, Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma, Oncogene, 36, 6006, 10.1038/onc.2017.205 · DOI
  42. Companioni Napoles, 2017, SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer, J. Gastroenterol., 52, 39, 10.1007/s00535-016-1202-4 · DOI
  43. Wan, 2020, Human schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription, Br. J. Cancer, 123, 633, 10.1038/s41416-020-0873-z · DOI
  44. Wan, 2019, SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3beta/beta-catenin pathway, Cell. Signal., 59, 1, 10.1016/j.cellsig.2019.03.004 · DOI
  45. Kabsch, 2010, Integration, scaling, space-group assignment and post-refinement, Acta Crystallogr. D. Biol. Crystallogr., 66, 133, 10.1107/S0907444909047374 · DOI · Paper page
  46. Kabsch, 2010, Xds, Acta Crystallogr. D. Biol. Crystallogr., 66, 125, 10.1107/S0907444909047337 · DOI · Paper page
  47. Grosse-Kunstleve, 2003, Substructure search procedures for macromolecular structures, Acta Crystallogr. Sect. D, 59, 1966, 10.1107/S0907444903018043 · DOI · Paper page
  48. Terwilliger, 2009, Decision-making in structure solution using bayesian estimates of map quality: the PHENIX autosol wizard, Acta Crystallogr. Sect. D, 65, 582, 10.1107/S0907444909012098 · DOI · Paper page
  49. Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D. Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  50. Stein, 2008, CHAINSAW: a program for mutating pdb files used as templates in molecular replacement, J. Appl. Crystallogr., 41, 641, 10.1107/S0021889808006985 · DOI · Paper page
  51. Winn, 2011, Overview of the CCP4 suite and current developments, Acta Crystallogr. D. Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 · DOI · Paper page
  52. McCoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  53. McCoy, 2013, SCEDS: protein fragments for molecular replacement in phaser, Acta Crystallogr. Sect. D, 69, 2216, 10.1107/S0907444913021811 · doi:10.1107/s0907444913021811
  54. Afonine, 2012, Towards automated crystallographic structure refinement with phenix.refine, Acta Crystallogr. D. Biol. Crystallogr., 68, 352, 10.1107/S0907444912001308 · DOI · Paper page
  55. Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr. D, 53, 240, 10.1107/S0907444996012255 · DOI · Paper page
  56. Vagin, 2004, REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use, Acta Crystallogr. Sect. D, 60, 2184, 10.1107/S0907444904023510 · DOI · Paper page
  57. Emsley, 2010, Features and development of coot, Acta Crystallogr. Sect. D, 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
  58. Pettersen, 2021, UCSF chimerax: structure visualization for researchers, educators, and developers, Protein Sci., 30, 70, 10.1002/pro.3943 · DOI · Paper page
  59. Zheng, 2017, MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy, Nat. Methods, 14, 331, 10.1038/nmeth.4193 · DOI · Paper page
  60. Punjani, 2017, cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination, Nat. Methods, 14, 290, 10.1038/nmeth.4169 · DOI · Paper page
  61. Punjani, 2020, Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction, Nat. Methods, 17, 1214, 10.1038/s41592-020-00990-8 · DOI · Paper page
  62. Lowary, 1998, New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning, J. Mol. Biol., 276, 19, 10.1006/jmbi.1997.1494 · DOI · Paper page
  63. Schneider, 2012, NIH image to imagej: 25 years of image analysis, Nat. Methods, 9, 671, 10.1038/nmeth.2089 · DOI · Paper page
  64. Murai, 2020, Chromatin remodeling and immediate early gene activation by SLFN11 in response to replication stress, Cell Rep., 30, 4137, 10.1016/j.celrep.2020.02.117 · DOI
  65. Jeong, 2003, Phosphorylated claspin interacts with a phosphate-binding site in the kinase domain of chk1 during ATR-mediated activation, J. Biol. Chem., 278, 46782, 10.1074/jbc.M304551200 · DOI
  66. Zhang, 2014, The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop, Cell Rep., 6, 421, 10.1016/j.celrep.2014.01.003 · DOI · Paper page
  67. Tanaka, 2012, STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway, Sci. Signal, 5, ra20, 10.1126/scisignal.2002521 · DOI · Paper page
  68. Walker, 1982, Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold, EMBO J., 1, 945, 10.1002/j.1460-2075.1982.tb01276.x · DOI · Paper page
  69. Yue, 2021, SLFN2 protection of tRNAs from stress-induced cleavage is essential for t cell-mediated immunity, Science, 372, eaba4220, 10.1126/science.aba4220 · DOI
  70. Chen, 2019, Deciphering the three-domain architecture in schlafens and the structures and roles of human schlafen12 and serpinB12 in transcriptional regulation, J. Mol. Graph. Model., 90, 59, 10.1016/j.jmgm.2019.04.003 · DOI

Cited by

See all 41

Metadata

Authors
Metzner, F. J., Huber, E., Hopfner, K.-P., & Lammens, K.
Venue
Nucleic Acids Research
Published
2022-01-17
Volume
50
Issue
2
Pages
1147-1161
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W4205335652
Cited by
41
References
9
FWCI
2.01
Type
journal article
Language
en
Open access
gold
Funders
  • Deutsche Forschungsgemeinschaft (210592381)
  • European Research Council (INO3D)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural and biochemical characterization of human Schlafen 5. https://app.cochat.ai/papers/10.1093/nar/gkab1278
The paper
Metzner, F. J., Huber, E., Hopfner, K.-P., & Lammens, K. (2022). Structural and biochemical characterization of human Schlafen 5. Nucleic Acids Research. https://doi.org/10.1093/nar/gkab1278

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.